ScreenerHero
NHINational Health Investors, Inc.
NYSE · US · Real Estate · REIT - Healthcare Facilities · nhireit.com
73.75USD-0.45%Mkt Cap: 3.64B $P/E: 21.41

National Health Investors, Inc. is a self-managed real estate investment trust (REIT). The Company owns, leases, operates and finances the development of high-quality real estate properties in the United States, focusing…

Industry Peers

REIT - Healthcare Facilities
Screen all
WELL
Welltower Inc.
$169.86BUSDP/E 105.2
VTR
Ventas, Inc.
$47.11BUSDP/E 167.0
OHI
Omega Healthcare Investors, Inc.
$14.80BUSDP/E 16.7
DOC
Healthpeak Properties, Inc.
$14.72BUSDP/E 59.3
CTRE
CareTrust REIT, Inc.
$9.41BUSDP/E 24.9
HR
Healthcare Realty Trust Incorporated
$6.78BUSD
AED
Aedifica SA
$6.17BUSDP/E 5.9
SBRA
Sabra Health Care REIT, Inc.
$5.25BUSDP/E 79.0
CSH-UN
Chartwell Retirement Residences
$5.06BUSDP/E 1054.0
PHP
Primary Health Properties PLC
$3.17BUSDP/E 15.9
MPT
Medical Properties Trust Inc. common stock
$2.48BUSD
LTC
LTC Properties, Inc.
$2.17BUSDP/E 14.4
DHC
Diversified Healthcare Trust
$1.96BUSD
SILA
Sila Realty Trust Inc. Common Stock
$1.68BUSDP/E 44.6
STRW
Strawberry Fields REIT Inc. Common Stock
$769.23MUSDP/E 20.9
NHP
National Healthcare Properties Inc. Class A Common Stock
$747.36MUSD
CPINV
Care Property Invest
$563.33MUSDP/E 8.1
UHT
Universal Health Realty Income Trust
$571.24MUSDP/E 29.6
XRN
Chiron Real Estate Inc. Common Stock
$533.88MUSDP/E 9.9
CHCT
Community Healthcare Trust Incorporated
$422.58MUSDP/E 22.1

Key Statistics

Company
Market Cap3.64B $
Enterprise Value5.05B $
Revenue (TTM)435.78M $
Gross Profit364.65M $
Net Income (TTM)142.18M $
Revenue/Share9.086 USD
Last Price73.75 USD
Fiscal Year EndDec 2025
MR QuarterMar 2021
Employees32
CountryUS
SectorReal Estate
IndustryREIT - Healthcare Facilities
ISINUS63633D1046
Valuation
P/E (Trailing)21.41
P/E (Forward)22.77
PEG4.76
EV/EBITDA17.44
EV/Revenue11.59
P/S8.33
P/B2.36
EPS (TTM)3.45
EPS (Forward)3.25
52W Range
67.9525% of range91.38
52W High91.38 USD
52W Low67.95 USD
Profitability
Gross Margin97.08%
Oper. Margin61.34%
EBITDA Margin66.47%
Profit Margin37.85%
ROE9.34%
ROA5.08%
Growth
Revenue Growth-2.60%
Earnings Growth-43.00%
Cash Flow & Leverage
Operating CF236.56M $
CapEx (TTM)—
FCF Margin39.47%
FCF Yield4.73%
Net Debt1.41B $
Net Debt/EBITDA4.87
Balance Sheet
Debt/Equity0.76
Current Ratio1.82
Quick Ratio1.20
Book Value/Sh31.26 USD
Cash/Share2.309 USD
Dividends
Fwd Div Rate3.760 USD
Trail. Div Rate3.680 USD
Div. Yield5.08%
5Y Avg Yield5.80%
Payout Ratio106.36%
Ex-Div DateSep 30, 2026
Pay DateNov 6, 2026
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)82.75 USD
Upside (mean)+12.2%
Target Range73.00 USD – 91.00 USD
$73.00+12.2% to mean$91.00
# Analysts8
Ownership
Shares Out.49.11M
Float47.94M
Insiders2.39%
Institutions79.53%
Short Interest
Short Ratio3.4d
Short % Float3.12%
Short % Out.3.05%
Shares Short1.50M
Short (prev mo.)3.74M
Technical
SMA 5075.38 (-2.2%)
SMA 20078.73 (-6.3%)
Beta0.56
S&P 52W Chg18.16%
Avg Vol (30d)281.49K
Avg Vol (10d)403.24K
Technical Indicators
RSI (14)46.6
MACD-1.1168
MACD Signal-0.8171
MACD Hist.-0.2998
BB Upper81.85 USD
BB Middle75.60 USD
BB Lower69.35 USD
BB Width16.53%
ATR (14)1.913 USD
Vol Ratio (20d)0.77x